Predicting vinorelbine disposition and toxicity: does BSA provide more than a "bad statistical association"?
Baker
Sharyn D
SD
Sparreboom
Alex
A
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism*; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D049628:Body Size; D001830:Body Surface Area; D005240:Feasibility Studies; D005838:Genotype; D006402:Hematologic Diseases / Q000139:chemically induced*; D006801:Humans; D020641:Polymorphism, Single Nucleotide; D018401:Sample Size; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D000077235:Vinorelbine
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine; D000077235:Vinorelbine